Man Group PLC Surmodics Inc Transaction History

Man Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.44 - $35.56 $257,634 - $333,872	9,389 New	9,389 $275,000
Q3 2023 Nov 14, 2023	BUY	$28.28 - $38.36 $223,496 - $303,159	7,903 New	7,903 $253,000
Q1 2021 May 17, 2021	SELL	$42.18 - $56.07 $697,277 - $926,893	-16,531 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$35.18 - $43.52 $18,750 - $23,196	-533 Reduced 3.12%	16,531 $720,000
Q3 2020 Nov 16, 2020	BUY	$37.98 - $48.72 $648,090 - $831,358	17,064 New	17,064 $664,000
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $1.38 Million - $1.72 Million	-36,225 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$41.26 - $58.35 $77,445 - $109,522	-1,877 Reduced 4.93%	36,225 $1.58 Million
Q4 2018 Feb 14, 2019	SELL	$44.93 - $73.38 $885,076 - $1.45 Million	-19,699 Reduced 34.08%	38,102 $1.8 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $516,084 - $729,417	9,078 Added 18.63%	57,801 $4.32 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $241,413 - $384,174	6,734 Added 16.04%	48,723 $2.69 Million
Q1 2018 May 15, 2018	BUY	$27.0 - $38.5 $1.13 Million - $1.62 Million	41,989 New	41,989 $1.6 Million

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.